1-(2-Amino-5-methylphenyl)-2,2,2-trifluoroethan-1-one, 95+%, 1g

2-amino-9-[(2R,3R,4S,5R)-5-(aminomethyl)-3,4-dihydroxyoxolan-2-yl]-6,9-dihydro-3H-purin-6-one, 97%, 1g

alpha-(4-Chlorophenyl)-2-pyridinemethanol>98.0%(GC)(T)1g

3-(4-Aminophenyl)-2-phenylpropanoic acid, 97%, 250mg

Bis(4-methylbenzyl) oxalate, 95.0%, 100g

1,4-Bis[2-(5-phényloxazolyl)]benzène min 99% pour scintillation 100g

Teinture Leishman, 5 g

1-(N-Methylpiperidin-4-yl-methyl)piperazine, 98.0%, 100mg

1-(Quinolin-2-yl)ethanone, 95.0%, 5g

Récipients en verre, 5,7 l 1 pièce

1-[4-(prop-2-yn-1-yloxy)phenyl]ethan-1-ol, 95%, 100mg

5-ETHYLIMIDAZOL, 97.0%, 1g

(1-Trityl-1H-pyrazol-4-yl)boronic acid, 95+%, 250mg